Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Will Generic Competitors Of Enbrel Affect Amgen's Stock Price?
Seeking Alpha
Saturday, June 15, 2013 - 12:58pm
tags:
Amgen, Enbrel, rheumatoid arthritis, arthritis, generics
Is Sequenom Stock Destined for Greatness?
Motley Fool
Saturday, June 15, 2013 - 12:56pm
tags:
Sequenom
Penny-Wise, Pound-Foolish Stem Cell Stocks
Seeking Alpha
Friday, June 14, 2013 - 12:23pm
tags:
stem cells, Osiris Therapeutics
These 2 Health Care Stocks Could Win Big With FDA's New 'Breakthrough' Status
Yahoo/Street Authority
Friday, June 14, 2013 - 12:21pm
tags:
FDA, breakthrough therapies, LDK378, Novartis, palbociclib, Pfizer, lambrolizumab, Merck
FLASH: Supreme Court unanimously rules that human genes aren't patentable
Mass Device
Friday, June 14, 2013 - 11:55am
tags:
legal, patent, devices
Japan prepares to cover cancer-related breast implants
FierceMedicalDevice
Friday, June 14, 2013 - 11:47am
tags:
Japan, Healthcare, devices, implants, cancer
Veniti reels in $9.7M for vein treatment device work
FierceMedicalDevice
Friday, June 14, 2013 - 11:47am
tags:
Veniti, treatment, funding, devices
Mindray commits $105M to grab U.S. ultrasound imaging company
FierceMedicalDevice
Friday, June 14, 2013 - 11:46am
tags:
Mindray, ultrasound, imaging, M&A, devices, ZONARE Medical Systems
Medtronic Announces CE Mark of Its ReDuX(TM) Plier Instrument, an Innovative Device to Perform Osteotomies in Spinal Deformity Surgeries
Yahoo/Reuters
Friday, June 14, 2013 - 11:41am
tags:
Medtronic, CE Mark, devices, surgical
Zimmer Announces Quarterly Dividend for Second Quarter of 2013
Yahoo/PRNewswire
Friday, June 14, 2013 - 11:41am
tags:
Zimmer, earnings, devices
Uroplasty places CFO on leave, delays filing annual report
Reuters
Friday, June 14, 2013 - 11:40am
tags:
Uroplasty, CFO, earnings, devices
EDAP Fully Redeems $8.0 Million Long-Term Debt
Yahoo/GlobeNewswire
Friday, June 14, 2013 - 11:39am
tags:
EDAP, debt, devices
Derma Sciences reports positive results from Phase 1 diabetic foot ulcer study
Yahoo/TheFlyOnTheWall
Friday, June 14, 2013 - 11:29am
tags:
Derma Sciences, diabetes, study, devices, research
Mindray Medical Appoints New Co-CEO
The Motley Fool
Friday, June 14, 2013 - 11:28am
tags:
Mindray, CEO, Management, devices
CR Bard to buyback $500M in common stock
Yahoo/AP
Friday, June 14, 2013 - 11:28am
tags:
CR Bard, devices, stock, stock buyback
FDA Nod for STJ's Ellipse & Assura
Yahoo/Zacks
Friday, June 14, 2013 - 11:27am
tags:
FDA, St. Jude Medical, Ellipse, Assura, devices
These Mutated Cystic Fibrosis Cells Are Worth Billions to Vertex Pharma
TheStreet.com
Friday, June 14, 2013 - 10:43am
tags:
cystic fibrosis, Vertex Pharmaceuticals
Pfizer's potential stars Eliquis, Xeljanz see sluggish sales
Fierce Pharma
Friday, June 14, 2013 - 10:36am
tags:
Pfizer, Eliquis, Xeljanz
AbbVie says it could beat Gilead to huge market for hep C drugs
Fierce Pharma
Friday, June 14, 2013 - 10:34am
tags:
AbbVie, Gilead, hepatitis C
Bristol-Myers Squibb and Simcere Enter Partnership to Co-Develop and Co-Commercialize Orencia(R) SC (abatacept) in China
Yahoo
Friday, June 14, 2013 - 10:27am
tags:
Bristol-Myers Squibb, China, Simcere, Orencia, rheumatoid arthritis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.